Love this. Unfortunately and scarily valid.

First 1522 Last

Share
Profile

Follow
JDBL

598 Posts.

93

29/01/25

23:29

Post #: 77613230
Share

Originally posted by What A Gas: ↑

(As a non expert) I regard DCF valuations, where there is a huge disjunct between current SP and any theoretical valuation as (I'm sorry) pie in the sky.

Not because they can't be reached, but because of the time span and attendant risk that must be overcome until the possible full value could be achieved.

For me, 2591 needs at least 2 convincing P3 successes before I would even dream of achieving a valuation of multi hundreds of dollars. Sure, get a couple of conditions for which 2591 is assured of getting to market and we could be talking turkey, but that is a long way off. Rigorous two arm, double blinded placebo controlled P3 trials are a different kettle of fish to our completed P2's. I can't see multi billions of dollars being risked until the potential becomes undeniable reality.

Added to the above, we are now living in a very unstable world, principally because of the way humans have desecrated the environmental health of our planet. A situation which is rapidly approaching a calamitous tipping point - it is almost too late to 'wake up'. Secondly the geo-political crises we face, due to nation state inequalities coupled with the greed of capitalism is an added layer of risk to our survival as a species.

The value of Neuren will not escape the possible ravages of these twin risks to the future and I dare say they not part of any risk adjusted DCF valuation.

Expand

Love this. Unfortunately and scarily valid.

NEU Price at posting: $14.43 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

PTX

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Expert Exchange: It's half time Down Under – How are we faring?

First 1522 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.93		Change 1.390(11.1%)		Mkt cap ! $1.559B

Open	High	Low	Value	Volume
$12.96	$13.93	$12.91	$4.215M	313.7K

Buyers (Bids)

No.	Vol.	Price($)
2	489	$13.92

Sellers (Offers)

Price($)	Vol.	No.
$13.93	676	2

View Market Depth

No.	Vol.	Price($)
1	228	13.830
2	323	13.820
5	569	13.810
5	1336	13.800
3	552	13.790

Price($)	Vol.	No.
13.880	1801	3
13.890	244	2
13.900	6218	8
13.910	1133	3
13.920	591	3

Last trade - 10.29am 26/06/2025 (20 minute delay)

NEU (ASX) Chart

Love this. Unfortunately and scarily valid.

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Expert Exchange: It's half time Down Under – How are we faring?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Love this. Unfortunately and scarily valid.

Top Stories

Prescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trial

ASX Market Open: Grand Nvidia comeback turns into 'sell' signpost for traders | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Expert Exchange: It's half time Down Under – How are we faring?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News